Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
The Biochemical Journal|April 16, 1998
Chicken FK506-binding protein, FKBP65, a member of the FKBP family of peptidylprolyl cis-trans isomerases, is only partially inhibited by FK506B Zeng, J R MacDonald, J G Bann, et al.
Medicine and Science in Sports and Exercise|December 29, 1999
Validity of predicting mean arterial blood pressure during exerciseJ D MacDougall, M Brittain, J R MacDonald, et al.
International Journal for Parasitology. Drugs and Drug Resistance|April 29, 2021
Antiplasmodial activity of the natural product compounds alstonine and himbelineM S J Arnold, J R Macdonald, R J Quinn, et al.
Canadian Journal of Physiology and Pharmacology|August 25, 2000
Myofibrillar disruption following acute concentric and eccentric resistance exercise in strength-trained menM J Gibala, S A Interisano, M A Tarnopolsky, et al.
Journal of Pediatric Hematology/Oncology|August 26, 2000
MGI 114: augmentation of antitumor activity when combined with topotecanS Weitman, H Barrera, R Moore, et al.
The Journal of Organic Chemistry|September 1, 2001
Structure-activity studies of antitumor agent irofulven (hydroxymethylacylfulvene) and analoguesT C McMorris, J Yu, R Lira, et al.
The Review of Scientific Instruments|February 2, 2015
Optical microscope and tapered fiber coupling apparatus for a dilution refrigeratorA J R MacDonald, G G Popowich, B D Hauer, et al.
European Journal of Applied Physiology and Occupational Physiology|February 24, 1999
Hypotension following mild bouts of resistance exercise and submaximal dynamic exerciseJ R MacDonald, J D MacDougall, S A Interisano, et al.
Anti-Cancer Drugs|December 10, 1999
Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming unitsM Hidalgo, E Izbicka, S G Eckhardt, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft modelL A Hammond, S G Hilsenbeck, S G Eckhardt, et al.
Pageof 9